MAPT and Alzheimer disease: However, as AD progresses, enhanced microglial activation, in response to advanced amyloid and tau pathology, leads to the excessive release of pro-inflammatory cytokines, which promote extensive inflammation, eventually leading to widespread neurodegeneration [25,26].